China-Led International Real-World Study: TACE Plus Immunotherapy Boosts Survival Beyond 26 Months in Unresectable HCC
Recently, a breakthrough was achieved in an international multi-center real‑world study led by Professors Ji-hui Hao and Ning-ning Zhang from the Tianjin Medical University Cancer Institute & Hospital. Through a…









